Tatjana Bilich

9PUBLICATIONS
47CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 17, 2026
Aging restricts maturation of CXCL13+ T follicular helper cells in human immunity.

|Nov 23, 2021
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity.

Jonas S Heitmann, Tatjana Bilich, Claudia Tandler

|Aug 23, 2021
SARS-CoV-2-reactive T-cell receptors isolated from convalescent COVID-19 patients confer potent T-cell effector function.

Fabian Brunk, Andreas Moritz, Annika Nelde

|May 20, 2021
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer.

Tatjana Bilich, Malte Roerden, Yacine Maringer

|Mar 16, 2021
T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals.

Tatjana Bilich, Annika Nelde, Jonas S Heitmann

|Oct 01, 2020
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.

Annika Nelde, Tatjana Bilich, Jonas S Heitmann

Pageof 2

Frequent Collaborators

7 joint publications

Annika Nelde

5 joint publications

Sebastian Hörber

5 joint publications

Malte Roerden

5 joint publications

Juliane Walz